These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
136 related items for PubMed ID: 34670598
21. Efficacy and safety evaluation of a novel trioxaquine in the management of cerebral malaria in a mouse model. Odhiambo OC, Wamakima HN, Magoma GN, Kirira PG, Malala BJ, Kimani FT, Muregi FW. Malar J; 2017 Jul 03; 16(1):268. PubMed ID: 28673299 [Abstract] [Full Text] [Related]
23. Comparative efficacy of intramuscular artemether and intravenous quinine in Nigerian children with cerebral malaria. Olumese PE, Björkman A, Gbadegesin RA, Adeyemo AA, Walker O. Acta Trop; 1999 Oct 15; 73(3):231-6. PubMed ID: 10546840 [Abstract] [Full Text] [Related]
24. An open randomized clinical trial in comparing two artesunate-based combination treatments on Plasmodium falciparum malaria in Nigerian children: artesunate/sulphamethoxypyrazine/pyrimethamine (fixed dose over 24 hours) versus artesunate/amodiaquine (fixed dose over 48 hours). Ayede IA, Falade AG, Sowunmi A, Jansen FH. Malar J; 2010 Dec 31; 9():378. PubMed ID: 21194422 [Abstract] [Full Text] [Related]
29. Comparison of combinations of parenteral artemisinin derivatives plus oral mefloquine with intravenous quinine plus oral tetracycline for treating cerebral malaria. Win K, Than M, Thwe Y. Bull World Health Organ; 1992 Dec 31; 70(6):777-82. PubMed ID: 1486675 [Abstract] [Full Text] [Related]
34. Rapid coma resolution with artemether in Malawian children with cerebral malaria. Taylor TE, Wills BA, Kazembe P, Chisale M, Wirima JJ, Ratsma EY, Molyneux ME. Lancet; 1993 Mar 13; 341(8846):661-2. PubMed ID: 8095573 [Abstract] [Full Text] [Related]
35. Comparison of artesunate and quinine in the treatment of severe Plasmodium falciparum malaria at Kassala hospital, Sudan. Abdallah TM, Elmardi KA, Elhassan AH, Omer MB, Elhag MS, Desogi MA, Siddig MF, Adam I. J Infect Dev Ctries; 2014 May 14; 8(5):611-5. PubMed ID: 24820465 [Abstract] [Full Text] [Related]
37. Efficacy and safety of re-treatment with the same artemisinin-based combination treatment (ACT) compared with an alternative ACT and quinine plus clindamycin after failure of first-line recommended ACT (QUINACT): a bicentre, open-label, phase 3, randomised controlled trial. Mavoko HM, Nabasumba C, da Luz RI, Tinto H, D'Alessandro U, Kambugu A, Baraka V, Rosanas-Urgell A, Lutumba P, Van Geertruyden JP. Lancet Glob Health; 2017 Jan 14; 5(1):e60-e68. PubMed ID: 27840069 [Abstract] [Full Text] [Related]
39. Comparison of artemisinin suppositories, intramuscular artesunate and intravenous quinine for the treatment of severe childhood malaria. Cao XT, Bethell DB, Pham TP, Ta TT, Tran TN, Nguyen TT, Pham TT, Nguyen TT, Day NP, White NJ. Trans R Soc Trop Med Hyg; 1997 Jan 14; 91(3):335-42. PubMed ID: 9231212 [Abstract] [Full Text] [Related]
40. Comparison of oral artesunate and quinine plus tetracycline in acute uncomplicated falciparum malaria. Karbwang J, Na-Bangchang K, Thanavibul A, Bunnag D, Chongsuphajaisiddhi T, Harinasuta T. Bull World Health Organ; 1994 Jan 14; 72(2):233-8. PubMed ID: 8205643 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]